Abstract:Potential conflict of interest: Nothing to report. TO THE EDITOR: We read the article by Seo et al.,1 in which the investigators reported that exosomes secreted by hepatocytes increase Toll‐like receptor 3 (TLR3) expression in hepatic stellate cells (HSCs) and activate HSCs, with great interest. Interleukin (IL)‐17A released by the activated HSCs further promotes IL‐17A production by γδ T cells and exacerbates liver fibrosis. This study improved our understanding of the pathogenesis of liver fibrosis. Consistent with their findings, our center recently showed that IL‐17A increased liver injury in a different model of liver diseases.2 However, we have some questions about IL‐17A production by activated HSCs and the effects of TLR3 on liver fibrosis. The investigators noted that hepatocyte‐released exosomes activated HSCs and accelerated IL‐17A production by HSCs, which subsequently amplified IL‐17A production from γδ T cells.1 IL‐17 is primarily produced by CD4+IL‐17+ T (Th17) cells, as well as other immune cells, including γδ T cells, natural killer (NK) T cells, NK cells, receptor‐related orphan receptor gamma t (RORγt)+ neutrophils, and eosinophils.3 So far, there has been no evidence that quiescent or activated HSCs produce IL‐17A. Furthermore, our center previously reported that HSC activation may not up‐regulate IL‐17A expression in these cells.2 We believe that IL‐17A promotion may be derived from exosomes, rather than HSCs, as was described in Seo et al.'s study, during the CCl4‐induced liver fibrillation. Thus, the sources of IL‐17A promotion require further research. Moreover, data showed that TLR3 deficiency in HSCs markedly attenuates liver fibrosis. TLR3 is primarily expressed in macrophages and dendritic cells, rather than HSCs, in the liver.4 However, TLRs expressed on HSCs, including TLR4 and TLR9 among others, share similar downstream signaling pathways, such as myeloid differentiation primary response gene 88 and Toll/IL‐1 receptor‐domain‐containing adapter‐inducing interferon‐β.4 The function of TLR3 may be replaced by activation of the same downstream pathway by other TLRs, especially TLR4. Previous studies have even found that TLR3 can have a protective effect against liver fibrosis.5 Therefore, we question whether TLR3 expression by HSCs plays a strong promoting role in the development of liver fibrosis. We agree with the investigators' conclusion that exosomes and IL‐17 have substantial roles in development of liver fibrosis. However, further confirmation that IL‐17A production by activated HSCs subsequently amplifies IL‐17A production from γδ T cells, and that TLR3 expression by HSCs plays an independent promoting role in liver fibrosis, is needed.

Interleukin-17 Promotes Activation of Human Hepatic Stellate Cells and Collagen Expression

IL-13 Induces STAT6 Phosphorylation and Promotes Fibrosis in Human Hepatic Stellate Cells

IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells

IL-13 Promotes Hepatic Stellate Cell Proliferation and Collagen Synthesizing

Il-17a Plays A Critical Role In The Pathogenesis Of Liver Fibrosis Through Hepatic Stellate Cell Activation

Wnt5a Promotes Cytokines Production and Cell Proliferation in Human Hepatic Stellate Cells Independent of Canonical Wnt Pathway.

Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

Hypoxia-inducible factor 1/IL-6 axis in activated hepatic stellate cells aggravates liver fibrosis

[Mechanism of Hepatic Stellate Cell Migration During Liver Fibrosis].

Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells

Targeting Transforming Growth Factor Βrii Expression Inhibits the Activation of Hepatic Stellate Cells and Reduces Collagen Synthesis

[Effects of CCN5 Overexpression on the Expression of Alpha-Sma and Collagen I in Hepatic Stellate Cells and Its Mechanism].

[An in Vivo Study on Interlukin-10 Inhibiting the Expression and Secretion of Collagen I and IV in Hepatic Stellate Cells].

Essential Role of Matrix Metalloproteinases in Interleukin-1-induced Myofibroblastic Activation of Hepatic Stellate Cell in Collagen

Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis Via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression.

IL-32γ Promotes Integrin Αvβ6 Expression Through the Activation of NF-κB in HSCs.

Serotonin-induced Mir-221/222 Contribute to the Activation of Hepatic Stellate Cells

Suppression of Hedgehog Signaling Regulates Hepatic Stellate Cell Activation and Collagen Secretion.

Increased IL-22-producing cells contribute to liver fibrosis through promoting Th17 migration in chronic HBV patients (P3363)

Comment on “exosome‐mediated Activation of Toll‐like Receptor 3 in Stellate Cells Stimulates Interleukin‐17 Production by Γδ T Cells in Liver Fibrosis”